Strategic Research Partner of the American Bar Association's Section of International LawThe Queen's Award for Enterpise 2012

Thomas H Beck

Thomas H Beck
Office:
Sidley Austin LLP
787 Seventh Avenue
10019
City:
New York
State:
New York
Country:
USA
Tel:
+1 212 839 5940
Fax:
+1 212 839 5599

Biography • Patents

Thomas H Beck is the head of Sidley's New York IP group, and focuses on complex chemical and pharmaceutical litigation matters. In February 2012 Mr Beck won a two week jury trial for Sunovion in Hatch-Waxman litigation against Mylan concerning the asthma medication Xopenex (levalbuterol), winning lost profits, reasonable royalty and a finding of willful infringement. The National Law Journal listed that verdict in the top 100 jury verdicts for 2012, and it was also in the top 20 IP jury awards for 2012. He is lead counsel for Noven Pharmaceuticals in Hatch-Waxman litigation against Watson concerning the Daytrana transdermal patch treatment for ADHD, and he is also lead counsel for ConvaTec in litigation brought by KCI and Wake Forest University concerning negative pressure wound therapy. He was recently lead IP counsel for LSI in litigation against Xilinx involving numerous patents relating to programmable field gate arrays and related circuits. He was lead counsel in several successful multi-million dollar mediation and arbitration efforts, including Marvell v Agere which involved 802.11 WiFi networks.

Mr Beck was lead or co-lead counsel for Eli Lilly and Company, Schering-Plough, GlaxoSmithKline, Bristol-Myers Squibb, Sanofi-Aventis and others, concerning matters such as the ADHD drug atomoxetine, the anticholesterol drug ezetimibe, the antidiabetic drug rosiglitazone maleate, the anti-cancer drug paclitaxel and the platelet inhibitor agent clopidogrel bisulfate. He was lead counsel for Bristol in the Bristol v RPR case, in which RPR's patent claims were found unenforceable, and the SDNY awarded Bristol's attorney fees for the six year battle.

Mr Beck received his JD from Harvard Law School in 1979 and his BS (with honors) from North Dakota State University in 1975.

This biography is an extract from The International Who's Who of Patents Lawyers which can be purchased from our Shop.

Biography • Life Sciences - Patent Litigation

Thomas H Beck is the head of the New York IP group, and focuses on complex pharmaceutical and medical device litigation. In February 2012, Mr Beck won a 2 week jury trial for Sunovion in Hatch-Waxman litigation against Mylan concerning the asthma medication Xopenex, winning lost profits, reasonable royalty and a finding of willful infringement. That verdict ranked among the top 100 jury verdicts for of listed in The National Law Journal, and it was also in the top 20 IP jury awards for 2012. He is lead counsel for Noven Pharmaceuticals in Hatch-Waxman litigation concerning the Daytrana transdermal patch for treating ADHD. He was lead counsel for ConvaTec in litigation brought by KCI and Wake Forest University concerning negative pressure wound therapy. Mr Beck has also been lead counsel in several successful multi-million dollar mediation and arbitration efforts, including Marvell v Agere which involved 802.11 WiFi networks.

Mr Beck is recognised as a 'litigation star in the United States' in the 2014 edition of Benchmark Litigation, and was selected as a 'Life Sciences Star' in the 2012 and 2013 editions of LMG Life Sciences. He was ranked in Who's Who Legal in 2010, where he was described as 'world class'. Mr Beck has been ranked in Chambers USA since 2005: 'extremely well-versed in patent law...tenacious litigation style...studious and organised approach'...ability to 'dig very deep into the science' of patent matters (2008) and 'a great thinker who gets into the details and works hard to come up with winning strategies' (2009). Mr Beck has presented on Hatch-Waxman issues at the ACI Paragraph IV litigation conferences in New York in 2007, 2008 and 2011, and at the Momentum Par IV conference in NY in 2013.

Mr Beck received his JD from Harvard Law School in 1979 and his BS (with honours) from North Dakota State University in 1975. Admissions include US Court of Appeals, Federal Circuit; US District Court, ED of New York; US District Court, SD of New York; New York.

This biography is an extract from The International Who's Who of Life Sciences Lawyers which can be purchased from our Shop.

Practice Areas

Firms

Browse Firms

Search Firms

The Who's Who Legal 100

Awards

News & Features

Special Reports

Events

Shop

About Us

It is not possible to buy entry into any Who's Who Legal publication

Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.

Copyright © 2014 Law Business Research Ltd. All rights reserved. | http://www.lbresearch.com

87 Lancaster Road, London, W11 1QQ, UK | Tel: +44 20 7908 1180 / Fax: +44 207 229 6910

http://www.whoswholegal.com | editorial@whoswholegal.com

Law Business Research Ltd

87 Lancaster Road, London
W11 1QQ, UK